LASSO (Figure 2D) and multivariate Cox regression analyses further verified that two genes (SLC11A1 and VEGFA) represented the optimal combination for evaluating GBM patient prognosis (Figure 2E). The gene discussed is SLC11A1; the disease is glioblastoma.